164.16k followers • 16 symbols Watchlist by Yahoo Finance
Follow this list to discover and track the stock of publicly traded companies with exposure to cannabis
Anheuser-Busch InBev SA/NV
Altria Group, Inc.
Molson Coors Beverage Company
The Scotts Miracle-Gro Company
Tilray Brands, Inc.
Cronos Group Inc.
Canopy Growth Corporation
Canopy Growth Corporation
Aurora Cannabis Inc.
Corbus Pharmaceuticals Holdings, Inc.
ETFMG Alternative Harvest ETF
In this article, we discuss 11 best marijuana stocks to buy now. If you want to see more stocks in this selection, check out 5 Best Marijuana Stocks To Buy Now. Previously, we reported that in 2022, the cannabis industry had a mixed performance, with some new markets experiencing growth while sales declined in established […]
In recent weeks, Anheuser-Busch Inbev has been struggling to deal with the public outcry over a social media advertising campaign it sponsored with transgender personality Dylan Mulvaney. Bud Light, the company's brand that has been leading U.S. beer sales for years, found itself at the center of the controversy. Now, AB Inbev is discontinuing its Babe wine and Hiball energy brands.
Readers hoping to buy Molson Coors Beverage Company ( NYSE:TAP ) for its dividend will need to make their move shortly...
It's safe to say that no one caught a pleasant buzz from Tilray Brands (NASDAQ: TLRY) stock on Friday. After market hours on Thursday, the ever cash-strapped Tilray announced it had launched a registered offering of $150 million worth of convertible senior notes. The notes are convertible at any time into Tilray common shares, with the initial conversion rate being just over 376.6 shares per $1,000 principal amount.
Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) announced today, that further to the Company's previously announced internal review of the financial reporting matters related to BioSteel Sports Nutrition Inc. (the "BioSteel Review") and the determination from the Company that it will need to restate its (i) audited consolidated financial statements for the fiscal year ended March 31, 2022, included in the Company's Annual Report on Form 10-K for the fiscal
In this article, we discuss 15 growth stocks to watch in Louis Navellier’s 2023 portfolio. If you want to see more stocks in this selection, check out Louis Navellier’s 2023 Portfolio: 5 Growth Stocks to Watch. According to a report featured on Markets Insider in October 2022, Louis Navellier of Navellier & Associates said that the […]
Shares of Target were on pace to close the week at their lowest levels in nearly three years. The seven-day selloff is partially about earnings, and partially about a decision to adjust its LGBTQ+ Pride Month collection. Target shares (ticker: TGT) have been falling since last week, dragged down by the company’s mixed first-quarter results.
Yahoo Finance Live discusses a drop in shares of cannabis stock Tilray after the company revealed it's registered offering price.
The Aussie dollar has broken down significantly during the trading week, as the 0.6 6 Level Has Given Way.
The Aussie dollar bounced a bit early on Friday to show signs of life again as we head into the weekend.
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
Make no mistake, Nvidia has captured the imagination of Wall Street.
RICHMOND, Va., May 26, 2023--Update on Altria’s Pending Acquisition of Njoy Holdings, Inc.
Refinances a meaningful portion of our debt due in June 2024, extending maturity to 2027 and locking in lower fixed interest rate of 5.20%; Strengthens balance sheet with additional cash proceeds of $15 million or $37 million if over-allotment is exercised in full, to be used for strategic acquisitions and to pay down debt; Brings the Company’s current cash, cash equivalents and marketable securities on hand to approximately $440 million. LEAMINGTON, Ontario and NEW YORK, May 25, 2023 (GLOBE NEW
Investing.com-- Australian retail sales missed expectations in April, remaining flat from the prior month as a rising cost of living and high interest rates saw consumers pulling back further on spending big.
Convertible notes offer lower interest expense and fewer covenant restrictions than our non-convertible debt options due to the conversion option value and are less dilutive than issuance of common stock A portion of the proceeds will be used to refinance existing debt LEAMINGTON, Ontario and NEW YORK, May 25, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today announced
As an increasing number of states legalize marijuana and the battle for top talent intensifies, the U.S. government revised its guidelines, shedding the vestiges of the "Just Say No" era. Don’t Miss: Why Jason Calacanis and Other Silicon Valley Elites Are Betting On This Startups Vision For Re-Uniting American Families For years, undergoing a drug test by providing a urine sample was a widely accepted albeit inconvenient prerequisite for starting a new job. But the legalization of marijuana in n
According to this crisis management expert, when companies like Target get political, the risk of losing loyal customers is real.
Dividend Kings have excellent track records for dividend growth, and are often seen as some of the safest income investments to own. Two dividend growth stocks that may look tempting and that investors may want to take a closer look at today are AbbVie (NYSE: ABBV) and 3M (NYSE: MMM). Healthcare company AbbVie pays a dividend yield of 4.1%, which is more than double the S&P 500 average of 1.7%.
Recently, Zacks.com users have been paying close attention to Altria (MO). This makes it worthwhile to examine what the stock has in store.
Last year revealed the importance of having safe stocks in your portfolio during times of market volatility. Enter dividend stocks. What's better than companies that have a track record of consistently paying and increasing dividends?
AbbVie (NYSE: ABBV) today announced the New England Journal of Medicine (NEJM) published results from the pivotal Phase 3 clinical trials – U-EXCEL, U-EXCEED and U-ENDURE – evaluating upadacitinib (RINVOQ®) in adult patients with moderately to severely active Crohn's disease who have had an inadequate response, lost response or were intolerant to conventional therapy or a biologic agent.1-4
The Aussie dollar had sold off rather drastically and Wednesday, and Thursday it looks like we are seeing more of the same.
SweetWater Brewing Company New American Lager The summer release of SweetWater's American Lager is here - a special edition of SweetWater’s flagship easy-drinking lager, featuring American red, white, and blue branding. SweetWater's New Brew American Lager Out Now SweetWater’s American Lager (4.5% alcohol by volume) is a refreshing, clean-bodied beer crafted with a 100% premium Pilsner grain bill and Crystal and Hallertau hops and brewed for easy summer-time drinking. ATLANTA, May 25, 2023 (GLOB
Tilray Medical Supports ONCOWELLNESS, Italy’s Leading Cancer Research and Patient Care ConferenceMILAN, Italy, May 25, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or “the Company”) (Nasdaq: TLRY; TSX: TLRY), a global leader in cannabis research, cultivation, production, and distribution, today announced that its medical cannabis division, Tilray Medical and FL Group, the Company’s subsidiary in Italy, have received authorization from Italy’s Ministry of Health to distribute three new